STAAR Surgical CompanySTAANASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
161.71%
↑ 146% above average
Average (39q)
-352.14%
Historical baseline
Range
High:621.61%
Low:-15607.81%
CAGR
+1.3%
Modest growth trend
| Period | Value |
|---|---|
| Q4 2025 | 161.71% |
| Q2 2025 | 47.80% |
| Q1 2025 | -105.66% |
| Q4 2024 | -591.20% |
| Q3 2024 | -52.24% |
| Q2 2024 | 621.61% |
| Q1 2024 | -121.92% |
| Q4 2023 | 65.29% |
| Q3 2023 | -26.78% |
| Q2 2023 | 207.04% |
| Q1 2023 | 190.46% |
| Q4 2022 | -92.97% |
| Q3 2022 | -19.48% |
| Q3 2022 | 40.51% |
| Q2 2022 | 64.07% |
| Q4 2021 | -5.79% |
| Q4 2021 | -26.41% |
| Q3 2021 | 42.56% |
| Q2 2021 | 83.22% |
| Q1 2021 | -16.49% |
| Q4 2020 | 562.75% |
| Q3 2020 | 7.05% |
| Q2 2020 | -148.46% |
| Q1 2020 | -29.75% |
| Q3 2019 | -27.69% |
| Q2 2019 | 194.63% |
| Q1 2019 | 31.84% |
| Q4 2018 | -25.02% |
| Q3 2018 | -47.69% |
| Q2 2018 | 278.72% |
| Q1 2018 | 163.41% |
| Q4 2017 | -220.81% |
| Q3 2017 | 179.02% |
| Q2 2017 | 36.99% |
| Q1 2017 | -266.80% |
| Q4 2016 | 173.24% |
| Q3 2016 | 19.93% |
| Q3 2016 | 78.69% |
| Q2 2016 | -15607.81% |
| Q1 2016 | 96.83% |